The TPMT*1 allele is assigned as a normal allele by CPIC. Patients carrying the TPMT*1 allele in combination with another normal function allele may have decreased likelihood of toxicity when treated with mercaptopurine as compared to patients with one or two no function alleles. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence mercaptopurine toxicity.